Alerts will be sent to your verified email
Verify Email
DLCL
|
Dr Lalchandani Labs
|
DhanvantriJeevan Rek
|
Clinitech Laboratory
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.8 % | -2.74 % | 23.22 % |
|
5yr average Equity Multiplier
|
1.66 | 1.5 | 1.96 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 1.16 | 1.44 |
|
5yr Avg Net Profit Margin
|
1.64 % | -2.7 % | 8.08 % |
|
Price to Book
|
0.0 | 0.89 | 0.0 |
|
P/E
|
21.77 | 20.99 | 25.36 |
|
5yr Avg Cash Conversion Cycle
|
251.31 Days | 39.88 Days | -80.2 Days |
|
Inventory Days
|
61.66 Days | 2.64 Days | 8.7 Days |
|
Days Receivable
|
366.94 Days | 37.5 Days | 30.99 Days |
|
Days Payable
|
236.74 Days | -1976.44 Days | 138.81 Days |
|
5yr Average Interest Coverage Ratio
|
2.93 | -2.62 | 10.19 |
|
5yr Avg ROCE
|
6.03 % | -1.98 % | 26.49 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | 2.45 % | 18.01 % |
|
5 yr average Debt to Equity
|
0.44 | 0.0 | 0.39 |
|
5yr CAGR Net Profit
|
5.7 % | n/a | -1.55 % |
|
5yr Average Return on Assets
|
2.22 % | -1.85 % | 11.7 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.32 % | 19.65 % | 61.58 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-12.46 % | -0.12 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dr Lalchandani Labs
|
DhanvantriJeevan Rek
|
Clinitech Laboratory
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|